4LSC2847 [13C5,15N]-Pemetrexed

Catalog Number: 4LSC2847
CAS #: N/A
Related CAS #: 137281-23-3 (unlabeled)
Name: [13C5,15N]-Pemetrexed; (4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoyl)-L-glutamic-13C5-15N acid

Pemetrexed is a folate analog metabolic inhibitor used to treat pleural mesothelioma and non-small cell lung cancer. Stable isotope labeled Pemetrexed is intended for use as an internal standard for the quantification of Pemetrexed by LC or GC-mass spectrometry.

If the number, nature and/or location of stable isotope label atoms (D, 15N, 13C) in this molecule don’t fit with your application, don’t hesitate to contact us to discuss your specific needs.

Keywords:

Stable isotope labeled active pharmaceutical ingredient (API), stable isotope dilution analysis, internal standard, stable isotope labeled standard (SIL), therapeutic drug monitoring (TDM), quantitative bioanalytical method validation, clinical diagnosis, LC/MS method validation, quantitative proteomics, selective reaction monitoring (SRM), multiple reaction monitoring (MRM), peptide based quantitative proteomics, custom stable isotope labeled (SIL) peptide, diagnostic breath test, clinical chemistry, diagnostic tools & biomarkers.

  • Molecular Formula: C1513C5H21N415NO6
  • Molecular Weight: 433.37 g/mol
  • Specification:
    Minimum chemical purity: 95.0 %
    Minimum Isotopic Enrichment: 13C ≥99 %, 15N ≥98%
  • Solubility: Methanol (MeOH), Dimethylsulfoxide (DMSO),
  • HS Code: 284590

N/A


You may also be interested in the following product: